Professor, Psychiatry and Behavioral Science, Stanford University Medical Center
Psychiatry
Dr. Alan Schatzberg, MD
|
|
Give Review
Doctor Alan Schatzberg, MD practices Psychiatry. He graduated from NYU School of Medicine. He received 4 awards: "America's Top Doctors", "Women's Health", "Elected Member" and "Whos Who in Medicine and Healthcare". Dr. Alan Schatzberg has written publications. He has 100 publications published with PubMed. The lastest publication is: 'Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders.' He accepts all Medicare patients.
Publications
- Evidence for alterations of the glial syncytial function in major depressive Disorder.
- Cognitive and emotional biomarkers of melancholic depression: An iSPOT-D report.
- Decreased hypothalamic functional connectivity with subgenual cortex in psychotic Major depression.
- ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
- The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment.
- ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.
- Coping and glucocorticoid receptor regulation by stress inoculation.
- Circadian dysregulation of clock genes: clues to rapid treatments in major depressive Disorder.
- Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?
- Neurobiological Signatures of Anxiety and Depression in Resting-State Functional Magnetic Resonance Imaging.
- Anna-Monika Award Lecture, DGPPN Kongress, 2013: The role of the hypothalamic-pituitary-adrenal (HPA) axis in the pathogenesis of psychotic Major depression.
- An empirical data comparison of regulatory agency and malpractice legal problems for psychiatrists.
- Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol.
- fMRI Activation During Executive Function Predicts Response to Cognitive Behavioral Therapy in Older, Depressed Adults.
- The unique impact of late-life bereavement and prolonged grief on diurnal cortisol.
- HPA axis genetic variation, cortisol and psychosis in Major depression.
- Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex.
- Pretreatment cortisol levels predict posttreatment outcomes among older adults with depression in cognitive behavioral therapy.
- BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression.
- Circadian patterns of gene expression in the human brain and disruption in major depressive Disorder.
- Glutamate transporters: A key piece in the glutamate puzzle of major depressive Disorder.
- Insular cortex abnormalities in psychotic Major depression: Relationship to gender and psychotic symptoms.
- Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive Disorder.
- Altered brain function underlying verbal memory encoding and retrieval in psychotic Major depression.
- Common Abnormalities and Disorder-Specific Compensation During Implicit Regulation of Emotional Processing in Generalized Anxiety and Major Depressive Disorders.
- Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy.
- Aberrant brain activation during a working memory task in psychotic Major depression.
- Expression patterns of corticotropin-releasing factor, arginine vasopressin, histidine decarboxylase, melanin-concentrating hormone, and orexin genes in the human hypo...
- Using treatment process data to predict maintained smoking abstinence.
- Animal models of early life stress: implications for understanding resilience.
- Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant Major depression: assessment of relapse during a 6-mo...
- Stress coping stimulates hippocampal neurogenesis in adult monkeys.
- ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression.
- Failure of anterior cingulate activation and connectivity with the amygdala during implicit regulation of emotional processing in generalized Anxiety disorder.
- FKBP5 polymorphisms and antidepressant response in geriatric depression.
- Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized Anxiety disorder.
- The Career Development Institute for Psychiatry: an innovative, longitudinal program for physician-scientists.
- Genome-wide association and meta-analysis of Bipolar disorder in individuals of European ancestry.
- The future of psychiatry as clinical neuroscience.
- Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression.
- The acute and post-discontinuation effects of a glucocorticoid receptor (GR) antagonist probe on sleep and the HPA axis in chronic insomnia: a pilot study.
- It is time to take a stand for medical research and against terrorism targeting medical scientists.
- Bridging the clinical gap: managing patients with co-occurring mood, Anxiety, and alcohol use disorders. Introduction.
- Achieving remission and favorable outcomes in patients with depression/Anxiety and substance use disorders.
- REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy:Rationale and Design.
- The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
- Preliminary evidence that hippocampal volumes in monkeys predict stress levels of adrenocorticotropic hormone.
- Resting-state functional connectivity in Major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus.
- The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
- Current issues in the classification of psychotic Major depression.
- Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.
- Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
- Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.
- Dissociable intrinsic connectivity networks for salience processing and executive control.
- Safety and tolerability of antidepressants: weighing the impact on treatment decisions.
- New paradigm for treating recurrent depression: from symptom control to managing enduring vulnerabilities.
- Social stress-related behavior affects hippocampal cell proliferation in mice.
- The neuropsychological profile of psychotic Major depression and its relation to cortisol.
- Cortisol circadian rhythm alterations in psychotic Major depression.
- Extended treatment with bupropion SR for cigarette smoking cessation.
- Clinical and biological effects of mifepristone treatment for psychotic depression.
- Application of microarray technology in primate behavioral neuroscience research.
- Maternal mediation, stress inoculation, and the development of neuroendocrine stress resistance in primates.
- Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research.
- From clinical research to clinical practice: a 4-year review of ziprasidone.
- The efficacy of divalproex sodium in the treatment of agitation associated with Major depression.
- The efficacy of antidepressants in the treatment of late-life depression.
- On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep Disorders.
- Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
- Aging and the role of the HPA axis and rhythm in sleep and memory-consolidation.
- Mild early life stress enhances prefrontal-dependent response inhibition in monkeys.
- A randomized trial of the efficacy of group therapy in changing viral load and CD4 counts in individuals living with HIV infection.
- Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric Major depression.
- Prospective investigation of stress inoculation in young monkeys.
- Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers.
- Cognitive correlates of white matter growth and stress hormones in female squirrel monkey adults.
- Pharmacologic treatments of Major depression: are two mechanisms really better than one?
- The relationship of chronic pain and depression.
- Employing pharmacologic treatment of Bipolar disorder to greatest effect.
- Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of Major depression and childhood trauma.
- Pharmacogenetics of antidepressant medication intolerance.
- Early maternal availability and prefrontal correlates of reward-related memory.
- Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of Major depression: a comparison of venlafaxine, selectiv...
- A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants.
- Using chronic pain to predict Depressive morbidity in the general population.
- Neuroendocrine aspects of hypercortisolism in Major depression.
- Regional analysis of hippocampal activation during memory encoding and retrieval: fMRI study.
- New approaches to managing psychotic depression.
- Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive Disorder.
- Introduction: treating depression and Anxiety to remission.
- Prevalence of Depressive episodes with psychotic features in the general population.
- Brain imaging in affective Disorders: more questions about causes versus effects.
- Developing novel treatments for mood Disorders: accelerating discovery.
- An open label trial of C-1073 (mifepristone) for psychotic Major depression.
- Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone.
- Recruiting and retaining future generations of physician scientists in mental health.
- Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of Major depression.
- Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders.
- NMDA antagonist treatment of depression.
Schools
New York University School Of Medicine
Lenox Hill Hospital
Mass Mental Health Center
Harvard University
Procedures Preformed
- Family Psychotherapy
- Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)
Conditions Treated
- Anxiety
- Bipolar Disorder
- Major Depressive Disorder
- Schizophrenia
Doctors Specialties
- Psychiatry
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- First Health (Coventry Health Care) PPO
- Covered California - Bronze PPO
- Health Net PPO
- Individual and Family PPO
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- PacifiCare HMO
Awards
- America's Top Doctors
- Women's Health
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
Lenox Hill Hospital -
NYU School of Medicine
Hospital
-
Stanford Health Care
Drug Facts
| NPI NUMBER | 1518093129 | |
| NPPES Provider LastName | SCHATZBERG | |
| NPPES Provider FirstName | ALAN | |
| NPPES Provider ZIPCode | 943052200 | |
| NPPES Provider State | CA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 153.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1518093129 |
| Last Name Of The Provider | SCHATZBERG |
| First Name Of The Provider | ALAN |
| View All |
Similar Doctors
|
|
Dr. Phyllis B. Thurstone, MD |
|
|
Dr. Bibi Das, MD |
|
|
Dr. Katherine Sanborn, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randall Weingarten, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manpreet K. Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Po W. Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Ashford Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer G. Luft, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah Yasmin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara R. Almond, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kiki D. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer R. Dore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas B. Kirsch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Greer Murphy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monica Sinha-Evenson, MD |
|
|
Dr. Valaiporn J. Rusmintratip, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Renate Trittelvitz, MD
This Doctor is OpenDoctor Recommended.
|